Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (831-840 of 1,482) with videos related to

Pageof 149
Sort By:
Cancer|December 7, 2018
Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypesPrajwal C Boddu, Tapan M Kadia, Guillermo Garcia-Manero, et al.
Transfusion Medicine (Oxford, England)|June 17, 2026
Functional validation of a modified platelet desialylation test for immune and hereditary thrombocytopeniasKaren Nogueira Chinoca Ziza, Thamy Caroline Silva, Mateus Domentino, et al.
Acta Haematologica|April 15, 2020
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid LeukemiasAbhishek Maiti, Miguel J Franquiz, Farhad Ravandi, et al.
Blood Cancer Journal|January 12, 2022
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Blood Advances|December 22, 2020
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AMLNicholas J Short, Hind Rafei, Naval Daver, et al.
Transfusion|December 2, 2017
Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*ΨMarcia Regina Dezan, Luis Giovani O Guardalini, Elaine Pessoa, et al.
The Journal of Physiology|June 23, 2015
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlationP Imbrici, L Maggi, G F Mangiatordi, et al.
Blood Cancer Journal|May 6, 2020
Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotypeBachar Samra, Guillaume Richard-Carpentier, Tapan M Kadia, et al.
Bone Marrow Transplantation|January 7, 2022
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplantSiba El Hussein, Courtney D DiNardo, Koichi Takahashi, et al.
Leukemia & Lymphoma|January 12, 2019
A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosisPrithviraj Bose, Mahesh Swaminathan, Naveen Pemmaraju, et al.
Pageof 149

Showing results (831-840 of 1,482) with videos related to

Sort By:
Pageof 149
Cancer|December 7, 2018
Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypesPrajwal C Boddu, Tapan M Kadia, Guillermo Garcia-Manero, et al.
Transfusion Medicine (Oxford, England)|June 17, 2026
Functional validation of a modified platelet desialylation test for immune and hereditary thrombocytopeniasKaren Nogueira Chinoca Ziza, Thamy Caroline Silva, Mateus Domentino, et al.
Acta Haematologica|April 15, 2020
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid LeukemiasAbhishek Maiti, Miguel J Franquiz, Farhad Ravandi, et al.
Blood Cancer Journal|January 12, 2022
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Blood Advances|December 22, 2020
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AMLNicholas J Short, Hind Rafei, Naval Daver, et al.
Transfusion|December 2, 2017
Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*ΨMarcia Regina Dezan, Luis Giovani O Guardalini, Elaine Pessoa, et al.
The Journal of Physiology|June 23, 2015
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlationP Imbrici, L Maggi, G F Mangiatordi, et al.
Blood Cancer Journal|May 6, 2020
Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotypeBachar Samra, Guillaume Richard-Carpentier, Tapan M Kadia, et al.
Bone Marrow Transplantation|January 7, 2022
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplantSiba El Hussein, Courtney D DiNardo, Koichi Takahashi, et al.
Leukemia & Lymphoma|January 12, 2019
A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosisPrithviraj Bose, Mahesh Swaminathan, Naveen Pemmaraju, et al.
Pageof 149